A polytherapy based approach to combat antimicrobial resistance using cubosomes

Abstract
A depleted antimicrobial drug pipeline combined with an increasing prevalence of Gram-negative ‘superbugs’ has increased interest in nano therapies to treat antibiotic resistance. As cubosomes and polymyxins disrupt the outer membrane of Gram-negative bacteria via different mechanisms, we herein examine the antimicrobial activity of polymyxin-loaded cubosomes and explore an alternative strategy via the polytherapy treatment of pathogens with cubosomes in combination with polymyxin. The polytherapy treatment substantially increases antimicrobial activity compared to polymyxin B-loaded cubosomes or polymyxin and cubosomes alone. Confocal microscopy and neutron reflectometry suggest the superior polytherapy activity is achieved via a two-step process. Firstly, electrostatic interactions between polymyxin and lipid A initially destabilize the outer membrane. Subsequently, an influx of cubosomes results in further membrane disruption via a lipid exchange process. These findings demonstrate that nanoparticle-based polytherapy treatments may potentially serve as improved alternatives to the conventional use of drug-loaded lipid nanoparticles for the treatment of “superbugs”. Open Access: This article is licensed under a Creative Commons Attribution 4.0 International Licence.
Description
Citation on Springer page at https://doi.org/10.1038/s41467-022-28012-5 lists author Jiang as Jhih-hang. Correct spelling is Jhih-Hang as per ORCiD 0000-0002-1543-1634.
Keywords
Drugs, Antibiotics, Drug delivery, Membranes, Therapy, Microbial drug resistance
Citation
Lai, X., Han, M.-L., Ding, Y., Chow, S. H., Le Brun, A. P., Wu, C. M., Bergen, P. J., Jiang, J-h, Hsu, H.-Y., Muir, B. W., White, J., Song, J., Li, J. & Shen, H.-H. (2022). A polytherapy based approach to combat antimicrobial resistance using cubosomes. Nature Communications, 13(1), 1-12. doi:10.1038/s41467-022-28012-5
Collections